论文部分内容阅读
目的探讨更昔洛韦治疗小儿呼吸道合胞病毒肺炎的临床疗效。方法选取2016年3月至2017年3月广东茂名石化医院收治的98例呼吸道合胞病毒肺炎患儿为研究对象,采取随机分配方式分为观察组和对照组,各49例。对照组患儿采用炎琥宁联合利巴韦林静脉滴注治疗,而观察组患儿则采用更昔洛韦联合利巴韦林静脉滴注抗病毒治疗措施,比较两组患儿的治疗效果。结果观察组患儿临床治疗总有效率比对照组高、各临床症状消退时间及总疗程比对照组短,差异均有统计学意义(均P<0.05)。结论采用更昔洛韦联合利巴韦林治疗小儿呼吸道合胞病毒肺炎临床疗效显著。
Objective To investigate the clinical efficacy of ganciclovir in the treatment of respiratory syncytial virus pneumonia in children. Methods A total of 98 children with respiratory syncytial virus pneumonia admitted in Maoming Petrochemical Hospital of Guangdong Province from March 2016 to March 2017 were selected as research object and divided randomly into observation group and control group with 49 cases in each group. The control group of children treated with Yan Hu Ning combined with ribavirin intravenous infusion, while the observation group were treated with ganciclovir combined with ribavirin intravenous antiviral therapy, the treatment of children in both groups . Results The total effective rate of clinical treatment in observation group was higher than that in control group. The regression time of each clinical symptom and the total duration of treatment were shorter than those in control group (all P <0.05). Conclusion Ganciclovir combined with ribavirin treatment of children with respiratory syncytial virus pneumonia clinical significant effect.